Fairvalue-Calculator Fairvalue-Calculator
EN DE

MYCELX Technologies Corporation (MYX) Fair Value & Analysis

Industrials · GB · Market cap 15.3M GBX

Pricep0.6550
Fair Valuep0.9700
Upside+48.1%
Quality92/100
Evidence: Low Range p0.7300 – p1.22

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

MYCELX Technologies Corporation (MYX) currently trades at p0.6550, while our model-based Fair Value estimate is p0.9700 — implying the stock looks roughly 48.1% undervalued today. We read business quality at 92/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

MYCELX Technologies Corporation, a clean water technology company, provides water treatment solutions to the PFAS remediation and produced water markets in the Middle East, the United States, Australia, and internationally. The company also sells and leases its equipment; and sells filtration media. It serves the oil and gas, power, marine, and heavy manufacturing sectors. The company was incorporated in 1994 and is headquartered in Norcross, Georgia.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is MYCELX Technologies Corporation (MYX) undervalued?
As of Jun 24, 2026, our model estimates a fair value of p0.9700 versus a price of p0.6550 — about +48% (undervalued). Model-based estimate, not financial advice.
What is the fair value of MYX?
Our 21-model fair value for MYCELX Technologies Corporation is p0.9700 (as of Jun 24, 2026), built from audited fundamentals. The current price is p0.6550.
What is the quality score of MYX?
MYCELX Technologies Corporation has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.